Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: Effect of the time of administration

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1020-1026

  LeBrun, Michel ^a   Grenier, Louis ^a   Gourde, Pierrette ^a   Bergeron, Michel G ^a   Labrecque, Gaston ^b   Beauchamp, Denis ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DNA; GENTAMICIN; N ACETYL BETA GLUCOSAMINIDASE; SPHINGOMYELIN PHOSPHODIESTERASE; THYMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; INJECTION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CORTEX; KIDNEY FUNCTION; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PYELONEPHRITIS; RAT; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL;

EID: 0032929891     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1020     Document Type: Article

References (52)

1. Ali, M. Z., and M. B. Goetz. 1997. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. 24:796-809.
2. Bailey, T. C., J. R. Little, B. Littenberg, R. M. Reichley, and W. C. Dunagan. 1997. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. 24:786-795.
3. Barza, M., J. P. Ioannidis, J. C. Cappelleri, and J. Lau. 1996. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312:338-345.
4. Beauchamp, D., P. Collin, L. Grenier, M. LeBrun, M. Couture, L. Thibault, G. Labrecque, and M. G. Bergeron. 1996. Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats. Antimicrob. Agents Chemother. 40:670-676.
5. Beauchamp, D., C. Guimont, L. Grenier, M. LeBrun, D. Tardif, P. Gourde, M. G. Bergeron, L. Thibault, and G. Labrecque. 1997. Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity. Antimicrob. Agents Chemother. 41:1468-1474.
6. Beauchamp, D., G. Labrecque, and M. G. Bergeron. 1995. [Is it still possible to reduce the incidence of nephrotoxicity of aminoglycosides?] Pathol. Biol. (Paris) 43:779-787. (In French.)
7. Beauchamp, D., G. Laurent, L. Grenier, P. Gourde, J. Zanen, J. A. Heuson Stiennon, and M. G. Bergeron. 1997. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin. Antimicrob. Agents Chemother. 41: 1237-1245.
8. Beauchamp, D., G. Laurent, P. Maldague, S. Abid, B. K. Kishore, and P. M. Tulkens. 1990. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J. Pharmacol. Exp. Ther. 255:858-866.
9. Beauchamp, D., M. Pellerin, P. Gourde, M. Pettigrew, and M. G. Bergeron. 1990. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob. Agents Chemother. 34:139-147.
10. Beauchamp, D., G. Theriault, L. Grenier, P. Gourde, S. Perron, Y. Bergeron, L. Fontaine, and M. G. Bergeron. 1994. Ceftriaxone protects against tobramycin nephrotoxicity. Antimicrob. Agents Chemother. 38:750-756.
11. Bergeron, M. G. 1989. Current concepts in the treatment of pyelonephritis. Intern. Med. 10:65-84.
12. Bergeron, M. G. 1995. Treatment of pyelonephritis in adults. Med. Clin. N. Am. 79:619-649.
13. Cambar, J., C. Dorian, and J. C. Cal. 1987. [Chronobiology and renal physiopatnology.] Pathol. Biol. (Paris) 35:977-984. (In French.)
14. Dorian, C., C. Bordenave, and J. Cambar. 1986. Circadian and seasonal variations in amikacin-induced acute renal failure evaluated by γ-glutamyl-transferase excretion changes. Annu. Rev. Chronopharmacol. 3:111-114.
15. Dorian, C., P. Catroux, and J. Cambar. 1987. [Chrononephrotoxicity of amikacin after 7-day chronic poisoning in rats.] Pathol. Biol. (Paris) 35:735-738. (In French.)
16. Dorian, C., P. Catroux, and J. Cambar. 1987. [Demonstration of seasonal changes of circadian rhythms of amikacin chrononephrotoxicity in rats.] Pathol. Biol. (Paris) 35:731-734. (In French.)
17. Doring, R., and L. Rensing. 1979. Daily changes of content and synthesis of electrophoretically separated RNA fractions in rat liver. J. Interdiscip. Cycle Res. 10:111-117.
18. Fantin, B., B. Pangon, G. Potel, J. M. Vallois, F. Caron, A. Bure, and C. Carbon. 1989. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrob. Agents Chemother. 33:767-770.
19. Fauconneau, B., E. De Lemos, C. Pariat, S. Bouquet, P. Courtois, and A. Piriou. 1992. Chrononephrotoxicity in rat of a vancomycin and gentamicin combination. Pharmacol. Toxicol. 71:31-36.
20. Ferriols Lisart, R., and M. Alos Alminana. 1996. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am. J. Health Syst. Pharm. 53:1141-1150.
21. Francioli, P. B., and M. P. Glauser. 1993. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37:207-212.
22. Galloe, A. M., N. Graudal, H. R. Christensen, and J. P. Kampmann. 1995. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur. J. Clin. Pharmacol. 48:39-43.
23. Hatala, R., T. Dinh, and D. J. Cook. 1996. Once-daily aminogtycoside dosing in immunocompetent adults: a meta-analysis. Ann. Intern. Med. 124:717-725.
24. Hosokawa, H., S. Nyu, K. Nakamura, K. Mifune, and S. Nakano. 1993. Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression. Chronobiol. Int. 10: 259-270.
25. Kahlmeter, G., and J. I. Dahlager. 1984. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J. Antimicrob. Chemother. 13(Suppl. A):9-22.
26. Kaye, D. 1971. The effect of water diuresis on spread of bacteria through the urinary tract. J. Infect. Dis. 124:297-305.
27. Komaroff, A. L. 1984. Acute dysuria in women. N. Engl. J. Med. 310:368-375.
28. Laurent, G., M. B. Carlier, B. Rollman, F. Van Hoof, and P. Tulkens. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31:3861-3870.
29. Laurent, G., P. Maldague, M. B. Carlier, and P. M. Tulkens. 1983. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob. Agents Chemother. 24:586-593.
30. Lin, L., L. Grenier, Y. Bergeron, M. Simard, M. G. Bergeron, G. Labrecque, and D. Beauchamp. 1994. Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats. Antimicrob. Agents Chemother. 38:54-60.
31. Lin, L., L. Grenier, C. Guimont, M. LeBrun, G. Labrecque, M. G. Bergeron, and D. Beauchamp. 1995. Circadian variation in the intracortical accumulation kinetics of tobramycin in conscious rats. Chronobiol. Int. 12:188-194.
32. Lin, L., L. Grenier, M. LeBrun, M. G. Bergeron, L. Thibault, G. Labrecque, and D. Beauchamp. 1996. Day-night treatment difference of tobramycin serum and intrarenal drug distribution and nephrotoxicity in rats: effects of fasting. Chronobiol. Int. 13:113-121.
33. Lin, L., L. Grenier, G. Theriault, P. Gourde, Y. Yoshiyama, M. G. Bergeron, G. Labrecque, and D. Beauchamp. 1994. Nephrotoxicity of low doses of tobramycin in rats: effect of the time of administration. Life Sci. 55:169-177.
34. Lucht, F., S. Tigaud, G. Esposito, J. Cougnard, M. P. Fargier, D. Peyramond, and J. L. Bertrand. 1990. Chronokinetic study of netilmicin in man. Eur. J. Clin. Pharmacol. 39:199-201.
35. Maruhn, D. 1976. Rapid colorimetric assay of beta-galactosidase and N-acetyl-beta-glucosaminidase in human urine. Clin. Chim. Acta 73:453-461.
36. Munckhof, W. J., M. L. Grayson, and J. D. Turnidge. 1996. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J. Antimicrob. Chemother. 37:645-663.
37. Nakano, S., and N. Ogawa. 1982. Chronotoxicity of gentamicin in mice. IRCS Med. Sci. 10:592-593.
38. Nakano, S., J. Song, and N. Ogawa. 1990. Chronopharmacokinetics of gentamicin: comparison between man and mice. Annu. Rev. Chronopharmacol. 7:277-280.
39. Pariat, C., J. Cambar, and P. Courtois. 1984. Circadian variations in the acute toxicity of three aminoglycosides: gentamicin, dibekacin, and netilmicin in mice. Annu. Rev. Chronopharmacol. 1:381-384.
40. Pariat, C., P. Courtois, J. Cambar, A. Piriou, and S. Bouquet. 1988. Circadian variations in the renal toxicology of gentamicin in rats. Toxicol. Lett. 40:175-182.
41. Patton, J. P., D. B. Nash, and E. Abrutyn. 1991. Urinary tract infection: economic considerations. Med. Clin. N. Am. 75:495-513.
42. Persijn, J. P., and W. van der Slik. 1976. A new method for the determination of gamma-glutamyltransferase in serum. J. Clin. Chem. Clin. Biochem. 14:421-427.
43. Pfeifer, U., and H. Scheller. 1975. A morphometric study of cellular autophagy including diurnal variations in kidney tubules of normal rats. J. Cell Biol. 64:608-621.
44. Prins, J. M., G. J. Weverling, R. J. van Ketel, and P. Speelman. 1997. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Clin. Pharmacol. Ther. 62:106-111.
45. Roelfsema, F., D. van der Heide, and D. Smeenk. 1980. Circadian rhythms of urinary electrolyte excretion in freely moving rats. Life Sci. 27:2303-2309.
46. Song, J., S. Ohdo, N. Ogawa, and S. Nakano. 1993. Influence of feeding schedule on chronopharmacological aspects of gentamicin in mice. Chronobiol. Int. 10:338-348.
47. Stamm, W. E., and T. M. Hooton. 1993. Management of urinary tract infections in adults. N. Engl. J. Med. 329:1328-1334.
48. Tolkoff Rubin, N. E., and R. H. Rubin. 1987. New approaches to the treatment of urinary tract infection. Am. J. Med. 82:270-277.
49. Yoshiyama, Y., L. Grenier, P. Gourde, M. Simard, L. Lin, N. J. Morin, M. G. Bergeron, G. Labrecque, and D. Beauchamp. 1996. Temporal variation in nephrotoxicity of low doses of isepamicin in rats. Antimicrob. Agents Chemother. 40:802-806.
50. Yoshiyama, Y., T. Kobayashi, S. Ohdo, N. Ogawa, M. G. Bergeron, G. Labrecque, D. Beauchamp, and N. Nakano. 1996. Dosing time-dependent changes of pharmacokinetics of isepamicin in man. J. Infect. Chemother. 2:106-109.
51. Yoshiyama, Y., T. Kobayashi, F. Tomonaga, and S. Nakano. 1992. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J. Antibiot. (Tokyo) 45:806-808.
52. Yoshiyama, Y., S. Nishikawa, T. Sugiyama, T. Kobayashi, H. Shimada, F. Tomonaga, S. Ohdo, N. Ogawa, and S. Nakano. 1993. Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob. Agents Chemother. 37:2042-2043.